{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:28:57Z","timestamp":1786652937942,"version":"build-2736575974"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Card Anaesth"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0971-9784.173028","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T08:03:54Z","timestamp":1452240234000},"page":"122","source":"Crossref","is-referenced-by-count":10,"title":["Perioperative management of patient with intracoronary stent presenting for noncardiac surgery"],"prefix":"10.4103","volume":"19","author":[{"given":"Indira","family":"Gurajala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0971-9784.173028-1","first-page":"1080","volume-title":"ABC of interventional cardiology: Percutaneous coronary intervention.I: History and development","author":"Grech","year":"2003","journal-title":"BMJ"},{"key":"key-10.4103\/0971-9784.173028-2","first-page":"195","volume-title":"Restenosis: Delineating the numerous causes of drug-eluting stent restenosis","author":"Farooq","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"key-10.4103\/0971-9784.173028-3","first-page":"957","volume-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-9784.173028-4","first-page":"14","volume-title":"Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty)","author":"Spaulding","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"key-10.4103\/0971-9784.173028-5","first-page":"159","volume-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"key-10.4103\/0971-9784.173028-6","first-page":"2584","volume-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-7","first-page":"2391","volume-title":"Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents","author":"Doyle","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/0971-9784.173028-8","first-page":"463","volume-title":"Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions","author":"Jensen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-9","first-page":"1497","volume-title":"The year in interventional cardiology","author":"Dixon","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-10","first-page":"1915","volume-title":"Stent thrombosis with drug-eluting stents: Is the paradigm shifting?","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-11","first-page":"301","volume-title":"The ABSORB bioresorbable vascular scaffold: An evolution or revolution in interventional cardiology?","author":"Gogas","year":"2012","journal-title":"Hellenic J Cardiol"},{"key":"key-10.4103\/0971-9784.173028-12","first-page":"213","volume-title":"Stent thrombosis in patients with coronary artery disease treated with biodegradable polymer drug-eluting stents: An update meta-analysis","author":"Zhang","year":"2014","journal-title":"Int Heart J"},{"key":"key-10.4103\/0971-9784.173028-13","first-page":"979","volume-title":"The current status of drug-coated balloons in percutaneous coronary and peripheral interventions","author":"Loh","year":"2013","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-14","first-page":"175","volume-title":"Nanoparticle drug - and gene-eluting stents for the prevention and treatment of coronary restenosis","author":"Yin","year":"2014","journal-title":"Theranostics"},{"key":"key-10.4103\/0971-9784.173028-15","first-page":"h1618","volume-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"key-10.4103\/0971-9784.173028-16","first-page":"1340","volume-title":"A new strategy for discontinuation of dual antiplatelet therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-17","first-page":"2088","volume-title":"Late angiographic stent thrombosis (LAST) events with drug-eluting stents","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-18","first-page":"2344","volume-title":"Clinical end points in coronary stent trials: A case for standardized definitions","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"key-10.4103\/0971-9784.173028-19","first-page":"947","volume-title":"Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation","author":"Ong","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-20","first-page":"989","volume-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0971-9784.173028-21","first-page":"920","volume-title":"Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry","author":"Berger","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"key-10.4103\/0971-9784.173028-22","first-page":"658","volume-title":"The incidence and timing of noncardiac surgery after cardiac stent implantation","author":"Hawn","year":"2012","journal-title":"J Am Coll Surg"},{"key":"key-10.4103\/0971-9784.173028-23","first-page":"186","volume-title":"Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation","author":"Rossini","year":"2011","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0971-9784.173028-24","first-page":"572","volume-title":"Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery","author":"Mahla","year":"2001","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0971-9784.173028-25","first-page":"442","volume-title":"The Platelet Activity After Clopidogrel Termination (PACT) study","author":"Frelinger","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"key-10.4103\/0971-9784.173028-26","first-page":"558","volume-title":"A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment","author":"Sibbing","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-27","first-page":"494","volume-title":"Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: A systematic review","author":"Hollis","year":"2012","journal-title":"Am J Surg"},{"key":"key-10.4103\/0971-9784.173028-28","first-page":"1229","volume-title":"Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents","author":"Van","year":"2009","journal-title":"Am J Cardiol"},{"key":"key-10.4103\/0971-9784.173028-29","doi-asserted-by":"crossref","unstructured":"Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK, et al. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: A systematic review and Bayesian approach network meta-analysis. Eur Heart J 2014;35:1147-58.","DOI":"10.1093\/eurheartj\/eht570"},{"key":"key-10.4103\/0971-9784.173028-30","first-page":"787","volume-title":"Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: A prospective multicentre study \u2032Prague 19\u2032","author":"Kocka","year":"2014","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0971-9784.173028-31","first-page":"1036","volume-title":"Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes","author":"Gori","year":"2014","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-32","first-page":"122","volume-title":"Noncardiac surgery after coronary stenting: Early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events","author":"Schouten","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-33","first-page":"1714","volume-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/0971-9784.173028-34","first-page":"687","volume-title":"Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: A meta-analysis of randomized and observational Studies","author":"Zimarino","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"key-10.4103\/0971-9784.173028-35","first-page":"1326","volume-title":"Incidence, predictors and management of left main coronary artery stent restenosis: A comprehensive review in the era of drug-eluting stents","author":"De","year":"2013","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-36","first-page":"1207","volume-title":"Immediate vs.delayed stenting in acute myocardial infarction: A systematic review and meta-analysis","author":"Freixa","year":"2013","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-37","first-page":"1662","volume-title":"Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention","author":"Park","year":"2013","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0971-9784.173028-38","first-page":"591","volume-title":"The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation","author":"Thayssen","year":"2012","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-39","first-page":"2126","volume-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"key-10.4103\/0971-9784.173028-40","first-page":"112","volume-title":"Comparison of drug-eluting and bare-metal stents in patients with diabetes undergoing primary percutaneous coronary intervention: What is the evidence?","author":"Gollop","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"key-10.4103\/0971-9784.173028-41","first-page":"517","volume-title":"Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: A meta-analysis based on 23,035 subjects","author":"Mao","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"key-10.4103\/0971-9784.173028-42","first-page":"1210","volume-title":"In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution","author":"Ascione","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"key-10.4103\/0971-9784.173028-43","first-page":"292","volume-title":"Antiplatelet drugs: A review of their pharmacology and management in the perioperative period","author":"Hall","year":"2011","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0971-9784.173028-44","first-page":"9","volume-title":"Review: Antiplatelet drugs: What comes next?","author":"Kei","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"key-10.4103\/0971-9784.173028-45","first-page":"i3","volume-title":"Perioperative management of antiplatelet therapy","author":"Oprea","year":"2013","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0971-9784.173028-46","first-page":"560","volume-title":"Coronary artery stents and non-cardiac surgery","author":"Howard-Alpe","year":"2007","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0971-9784.173028-47","first-page":"2785","volume-title":"Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery","author":"Capodanno","year":"2013","journal-title":"Circulation"},{"key":"key-10.4103\/0971-9784.173028-48","first-page":"2933","volume-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial","author":"Becker","year":"2011","journal-title":"Eur Heart J"},{"key":"key-10.4103\/0971-9784.173028-49","first-page":"531","volume-title":"Does clopidogrel affect outcome after coronary artery bypass grafting.A meta-analysis?","author":"Purkayastha","year":"2006","journal-title":"Heart"},{"key":"key-10.4103\/0971-9784.173028-50","first-page":"734","volume-title":"Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans","author":"Ernst","year":"2006","journal-title":"Chest"},{"key":"key-10.4103\/0971-9784.173028-51","first-page":"2533","volume-title":"ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","author":"Abraham","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0971-9784.173028-52","first-page":"1848","volume-title":"Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: A systematic review of clinical practice guidelines","author":"Darvish-Kazem","year":"2013","journal-title":"Chest"},{"key":"key-10.4103\/0971-9784.173028-53","first-page":"2215","volume-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Fleisher","year":"2014","journal-title":"Circulation"},{"key":"key-10.4103\/0971-9784.173028-54","first-page":"514","volume-title":"Coronary stents and subsequent surgery: Reported provider attitudes and practice patterns","author":"Graham","year":"2013","journal-title":"Am Surg"},{"key":"key-10.4103\/0971-9784.173028-55","first-page":"73","volume-title":"Preoperative management of antiplatelet drugs for a coronary artery stent: How can we hit a moving target?","author":"Vetter","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"key-10.4103\/0971-9784.173028-56","first-page":"686","volume-title":"Coronary artery stenting and non-cardiac surgery - A prospective outcome study","author":"Vicenzi","year":"2006","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0971-9784.173028-57","first-page":"580","volume-title":"Perioperative management of antiplatelet agents in patients with coronary stents: Recommendations of a French Task Force","author":"Albaladejo","year":"2006","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0971-9784.173028-58","first-page":"19","volume-title":"Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery","author":"Broad","year":"2007","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0971-9784.173028-59","first-page":"285","volume-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: A phase II study of \u2032bridging\u2032 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0971-9784.173028-60","first-page":"2133","volume-title":"Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery","author":"Savonitto","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key-10.4103\/0971-9784.173028-61","first-page":"204","volume-title":"Outcomes of a preoperative \"bridging\" strategy with glycoprotein IIb\/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration","author":"Alshawabkeh","year":"2013","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-62","first-page":"1350","volume-title":"Cangrelor versus clopidogrel in percutaneous coronary intervention: A systematic review and meta-analysis","author":"Pandit","year":"2014","journal-title":"EuroIntervention"},{"key":"key-10.4103\/0971-9784.173028-63","first-page":"265","volume-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"key-10.4103\/0971-9784.173028-64","first-page":"644","volume-title":"Case scenario: A patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention","author":"Naik","year":"2014","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0971-9784.173028-65","first-page":"134","volume-title":"The preoperative bleeding time test lacks clinical benefit: College of American Pathologists\u2032 and American Society of Clinical Pathologists\u2032 position article","author":"Peterson","year":"1998","journal-title":"Arch Surg"},{"key":"key-10.4103\/0971-9784.173028-66","first-page":"963","volume-title":"Avoidance of bleeding during surgery in patients receiving anticoagulant and\/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations","author":"Harder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0971-9784.173028-67","first-page":"1215","volume-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","author":"Buonamici","year":"2011","journal-title":"JAMA"},{"key":"key-10.4103\/0971-9784.173028-68","first-page":"734","volume-title":"Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents","author":"Gori","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key-10.4103\/0971-9784.173028-69","first-page":"e234","volume-title":"Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies","author":"Morel-Kopp","year":"2010","journal-title":"Thromb Res"},{"key":"key-10.4103\/0971-9784.173028-70","first-page":"151","volume-title":"Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting","author":"Sibbing","year":"2010","journal-title":"Thromb Haemost"},{"key":"key-10.4103\/0971-9784.173028-71","first-page":"45","volume-title":"The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting","author":"Mishra","year":"2015","journal-title":"Ann Card Anaesth","ISSN":"https:\/\/id.crossref.org\/issn\/0971-9784","issn-type":"print"},{"key":"key-10.4103\/0971-9784.173028-72","first-page":"325","volume-title":"Clopidogrel (Plavix) and cardiac surgical patients: Implications for platelet function monitoring and postoperative bleeding","author":"Tanaka","year":"2004","journal-title":"Platelets"},{"key":"key-10.4103\/0971-9784.173028-73","first-page":"878","volume-title":"Bleeding in a patient receiving platelet aggregation inhibitors","author":"Waters","year":"2001","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0971-9784.173028-74","first-page":"133","volume-title":"Platelet function tests: A comparative review","author":"Paniccia","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/0971-9784.173028-75","first-page":"64","volume-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"key-10.4103\/0971-9784.173028-76","first-page":"303","volume-title":"Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia","author":"Horlocker","year":"1995","journal-title":"Anesth Analg"},{"key":"key-10.4103\/0971-9784.173028-77","first-page":"619","volume-title":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","author":"CLASP:","year":"1994","journal-title":"Lancet"},{"key":"key-10.4103\/0971-9784.173028-78","first-page":"421","volume-title":"A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans","author":"Jakubowski","year":"2007","journal-title":"Br J Clin Pharmacol"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:25Z","timestamp":1786649305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0971-9784.173028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["173028"],"URL":"https:\/\/doi.org\/10.4103\/0971-9784.173028","relation":{},"ISSN":["0971-9784"],"issn-type":[{"value":"0971-9784","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}